Faculty Opinions recommendation of Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with MYC and BCL2 rearrangements.

作者
Corrado Girmenia
出处
期刊:
标识
DOI:10.3410/f.734628348.793562625
摘要

The so-called "double-hit" and "double-protein-expression" lymphoma with MYC and BCL2 rearrangements is a rare, mature B-cell neoplasm characterized by a germinal center B-cell phenotype, abundant protein expression of MYC and BCL2, rapid disease progression, and a poor prognosis. In this study, we showed the potential benefit of the BCL2 inhibitor venetoclax in the treatment of this disease. Immunohistochemical studies of the lymphoma tissues confirmed that overexpression of MYC and BCL2 was observed more frequently in this subtype than in other germinal center B-cell-like diffuse large B-cell lymphomas. In contrast, another pro-survival protein MCL1 was less expressed in this subtype, even when compared with its expression in the non-"double-hit" and "double-protein-expression" type. Furthermore, in vitro studies using two "double-hit" and "double-protein-expression" lymphoma-derived cell lines, Karpas231 and OCI-Ly8, clearly showed that a low concentration of venetoclax, but not the MCL1 inhibitor S63845, was sufficient to induce apoptosis in the two lines, compared with in other germinal center B-cell-derived cell lines, BJAB and SU-DHL10. These results indicate that the survival of this type of lymphoma depends predominantly on BCL2 rather than on MCL1. Unexpectedly, we found that venetoclax not only disrupts the interaction between BCL2 and the pro-apoptotic protein BIM, but also leads to dephosphorylation of BCL2 and further downregulates MCL1 protein expression, probably through modulation of the protein phosphatase 2A B56α activity in Karpas231 and OCI-Ly8. Indeed, a low concentration of venetoclax induced substantial apoptosis in the primary lymphoma cells, regardless of high protein expression of MCL1 associated with venetoclax resistance. Venetoclax clearly triggers the signal transduction related to BCL2 and MCL1 in "double-hit" and "double-protein-expression" lymphoma cells.Copyright© 2019 Ferrata Storti Foundation. PMID: 30523053

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
ad9完成签到,获得积分10
1秒前
Lucas应助wjthhhh采纳,获得10
1秒前
1秒前
李健的小迷弟应助嗯嗯采纳,获得10
1秒前
忐忑的三问完成签到,获得积分20
1秒前
yltstt完成签到,获得积分10
2秒前
2秒前
2秒前
3秒前
3秒前
小蘑菇应助冬月初七采纳,获得10
4秒前
4秒前
paek完成签到,获得积分10
4秒前
高高听莲完成签到,获得积分10
4秒前
4秒前
4秒前
王重阳发布了新的文献求助10
4秒前
ZhQ发布了新的文献求助10
4秒前
zzb关闭了zzb文献求助
5秒前
搜集达人应助M1AO采纳,获得10
5秒前
安然发布了新的文献求助10
5秒前
5秒前
归海浩阑完成签到,获得积分10
5秒前
5秒前
5秒前
小二郎应助忐忑的三问采纳,获得10
6秒前
6秒前
江心秋月完成签到,获得积分10
6秒前
橙子发布了新的文献求助10
6秒前
浪子应助wicky采纳,获得10
6秒前
114514发布了新的文献求助10
6秒前
zch发布了新的文献求助10
6秒前
Su_Zehe完成签到,获得积分10
7秒前
刘洞洞发布了新的文献求助10
7秒前
7秒前
高高的曼柔完成签到,获得积分10
7秒前
8秒前
无极微光应助谜迪采纳,获得20
8秒前
Hazzz发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Navigating Normative Orders. Interdisciplinary Perspectives 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7762285
求助须知:如何正确求助?哪些是违规求助? 9307054
关于积分的说明 20298015
捐赠科研通 7346892
什么是DOI,文献DOI怎么找? 3313417
关于科研通互助平台的介绍 2463517
邀请新用户注册赠送积分活动 2327740